Year archive

NYRADA INC. — 2025 filings

All 129 regulatory filings released by NYRADA INC. (NYR) in 2025, sourced directly from the official regulator.

129 Filings

2025 Period

2025 filings (129)

Filing	Released	Lang
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-12-30	English
Cleansing Statement 2 pages 232.3KB Regulatory Filings	2025-12-30	English
Change of Director's Interest Notice - ID 2 pages 5.9KB Regulatory Filings	2025-12-21	English
Upcoming Expiry of Unlisted Options 2 pages 249.1KB Regulatory Filings	2025-12-18	English
Application for quotation of securities - NYR 6 pages 19.3KB Regulatory Filings	2025-12-09	English
Cleansing Statement 2 pages 253.9KB Regulatory Filings	2025-12-09	English
Change of Director's Interest Notice - CC 3 pages 7.2KB Regulatory Filings	2025-12-09	English
Change of Director's Interest Notice - RW 2 pages 5.9KB Regulatory Filings	2025-12-09	English
Change of Director's Interest Notice - MF 2 pages 5.9KB Regulatory Filings	2025-12-09	English
Change of Director's Interest Notice - JM 2 pages 6.0KB Regulatory Filings	2025-12-09	English
Application for quotation of securities - NYR 6 pages 18.4KB Regulatory Filings	2025-12-04	English
Cleansing Statement 2 pages 232.9KB Regulatory Filings	2025-12-04	English
Change of Director's Interest Notice - RW 2 pages 6.3KB Regulatory Filings	2025-12-04	English
Change of Director's Interest Notice - MF 2 pages 6.3KB Regulatory Filings	2025-12-04	English
Change of Director's Interest Notice - JM 3 pages 7.5KB Regulatory Filings	2025-12-04	English
Investor Presentation 3 pages 237.0KB Regulatory Filings	2025-11-25	English
Capital Structure 3 pages 254.3KB Regulatory Filings	2025-11-24	English
Becoming a substantial holder - Matt Corp WA PL 2 pages 224.5KB Regulatory Filings	2025-11-23	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-11-23	English
Cleansing Statement 3 pages 240.0KB Regulatory Filings	2025-11-23	English
Nyrada Phase IIa Clinical Trial Update 6 pages 328.0KB Regulatory Filings	2025-11-17	English
Application for quotation of securities - NYR 8 pages 24.0KB Regulatory Filings	2025-11-12	English
Cleansing Statement 3 pages 240.0KB Regulatory Filings	2025-11-12	English
AGM Presentation 17 pages 2.4MB Regulatory Filings	2025-11-11	English
AGM Chair Address 4 pages 230.3KB Regulatory Filings	2025-11-11	English
Results of Meeting 4 pages 261.7KB Regulatory Filings	2025-11-11	English
Notification of cessation of securities - NYR 4 pages 14.9KB Regulatory Filings	2025-11-11	English
Change of Director's Interest Notice 2 pages 5.9KB Regulatory Filings	2025-11-11	English
Final Director's Interest Notice 2 pages 4.2KB Regulatory Filings	2025-11-11	English
Investor Presentation and CEO AGM Presentation 19 pages 2.6MB Regulatory Filings	2025-11-09	English
Upcoming Release of Securities from Voluntary Escrow 2 pages 259.1KB Regulatory Filings	2025-11-06	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-11-04	English
Cleansing Statement 3 pages 253.8KB Regulatory Filings	2025-11-04	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-11-02	English
Cleansing Statement 3 pages 245.8KB Regulatory Filings	2025-11-02	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-10-21	English
Cleansing Statement 2 pages 235.2KB Regulatory Filings	2025-10-21	English
Quarterly Activities Report and Appendix 4C 10 pages 559.1KB Regulatory Filings	2025-10-20	English
Nyrada Selects Accelagen as CRO for Phase IIa Clinical Trial 2 pages 248.0KB Regulatory Filings	2025-10-12	English
Nyrada Board Transition and CEO Remuneration Review 2 pages 233.6KB Regulatory Filings	2025-10-07	English
Initial Director's Interest Notice - JB 2 pages 4.4KB Regulatory Filings	2025-10-07	English
2025 AGM Letter to Shareholders, Notice of Meeting & Proxy 64 pages 2.1MB Regulatory Filings	2025-10-07	English
Notification of cessation of securities - NYR 4 pages 14.9KB Regulatory Filings	2025-10-07	English
Application for quotation of securities - NYR 6 pages 18.5KB Regulatory Filings	2025-10-01	English
Cleansing Statement 2 pages 257.6KB Regulatory Filings	2025-10-01	English
Nyrada 2025 Equity Incentive Plan 34 pages 726.6KB Regulatory Filings	2025-09-30	English
Xolatryp Achieves Key Clinical Milestone 4 pages 309.4KB Regulatory Filings	2025-09-28	English
Xolatryp Protects Cells through Mitochondrial Stabilisation 4 pages 354.3KB Regulatory Filings	2025-09-15	English
Change in substantial holding - M Azzi 2 pages 257.2KB Regulatory Filings	2025-09-10	English
Application for quotation of securities - NYR 6 pages 18.3KB Regulatory Filings	2025-09-08	English
Cleansing Statement 2 pages 235.9KB Regulatory Filings	2025-09-08	English
Securities Trading Policy 8 pages 391.8KB Regulatory Filings	2025-08-21	English
Preliminary Final Report 2 pages 446.6KB Regulatory Filings	2025-08-21	English
Appendix 4G and Corporate Governance Statement 25 pages 1.0MB Regulatory Filings	2025-08-21	English
Annual Report for year ended 30 June 2025 65 pages 2.9MB Regulatory Filings	2025-08-21	English
Full Year Results FY2025 4 pages 265.6KB Regulatory Filings	2025-08-21	English
Notification regarding unquoted securities - NYR 6 pages 20.4KB Regulatory Filings	2025-08-21	English
Application for quotation of securities - NYR 6 pages 18.4KB Regulatory Filings	2025-08-21	English
Cleansing Statement 2 pages 231.8KB Regulatory Filings	2025-08-21	English
Notification regarding unquoted securities - NYR 9 pages 30.0KB Regulatory Filings	2025-08-19	English
Response to ASX Cleansing Notice Timing Letter 8 pages 574.6KB Regulatory Filings	2025-08-13	English
NYR Appoints Consultant Cardiologist for Phase IIa Trial 2 pages 221.2KB Regulatory Filings	2025-08-12	English
Application for quotation of securities - NYR 6 pages 18.2KB Regulatory Filings	2025-08-12	English
Cleansing Statement 2 pages 254.1KB Regulatory Filings	2025-08-12	English
Application for quotation of securities - NYR 6 pages 18.5KB Regulatory Filings	2025-08-10	English
Cleansing Statement 2 pages 238.6KB Regulatory Filings	2025-08-10	English
BioShares Biotech Summit Presentation 12 pages 1.6MB Regulatory Filings	2025-08-05	English
Positive Final Review of Nyrada Phase I Clinical Trial 4 pages 269.9KB Regulatory Filings	2025-08-05	English
Change in substantial holding - M Azzi 4 pages 444.8KB Regulatory Filings	2025-08-04	English
Nyrada Successfully Raises $8.25 Million via Placement 4 pages 329.9KB Regulatory Filings	2025-08-03	English
Proposed issue of securities - NYR 7 pages 24.2KB Regulatory Filings	2025-08-03	English
Proposed issue of securities - NYR 5 pages 18.1KB Regulatory Filings	2025-08-03	English
Application for quotation of securities - NYR 6 pages 18.6KB Regulatory Filings	2025-08-03	English
Application for quotation of securities - NYR 6 pages 18.4KB Regulatory Filings	2025-08-03	English
Cleansing Statement 2 pages 246.9KB Regulatory Filings	2025-08-03	English
Top 20 CDI Holder List 4 pages 250.2KB Regulatory Filings	2025-07-30	English
Quarterly Activities Report and Appendix 4C 10 pages 549.0KB Regulatory Filings	2025-07-30	English
Trading Halt 3 pages 359.6KB Regulatory Filings	2025-07-30	English
Change in substantial holding - M Azzi 2 pages 240.3KB Regulatory Filings	2025-07-30	English
NYR Advances Xolatryp Phase IIa Trial in Cardioprotection 5 pages 304.7KB Regulatory Filings	2025-07-22	English
Final Phase I Clinical Trial Patients Dosed and Discharged 4 pages 306.4KB Regulatory Filings	2025-07-20	English
Final Nyrada Phase I Clinical Trial Cohort to Commence 4 pages 305.9KB Regulatory Filings	2025-07-13	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 226.6KB Regulatory Filings	2025-07-03	English
Proposed issue of securities - NYR 5 pages 17.7KB Regulatory Filings	2025-06-29	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 225.2KB Regulatory Filings	2025-06-24	English
Non-Deal Investor Presentation 23 pages 2.5MB Regulatory Filings	2025-06-15	English
Nyrada Investor Conference Call 2 pages 280.4KB Regulatory Filings	2025-06-15	English
Phase I Clinical Trial Dosing Update No 4 4 pages 289.7KB Regulatory Filings	2025-06-15	English
Notification of cessation of securities - NYR 5 pages 16.8KB Regulatory Filings	2025-06-12	English
Change of Director's Interest Notice - JM 3 pages 7.6KB Regulatory Filings	2025-06-12	English
Change of Director's Interest Notice - CC 3 pages 7.7KB Regulatory Filings	2025-06-12	English
Change of Director's Interest Notice - MF 3 pages 7.6KB Regulatory Filings	2025-06-12	English
Change of Director's Interest Notice - RW 3 pages 7.6KB Regulatory Filings	2025-06-12	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 240.0KB Regulatory Filings	2025-06-11	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 226.3KB Regulatory Filings	2025-06-04	English
Phase I Clinical Trial Protocol Amendment 4 pages 282.2KB Regulatory Filings	2025-06-03	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 235.9KB Regulatory Filings	2025-06-02	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 221.9KB Regulatory Filings	2025-05-27	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 235.9KB Regulatory Filings	2025-05-25	English
Lead Drug Candidate Renamed to Xolatryp 3 pages 268.7KB Regulatory Filings	2025-05-22	English
Change of Director's Interest Notice - CC 4 pages 8.9KB Regulatory Filings	2025-05-20	English
Change of Director's Interest Notice - RW 4 pages 9.0KB Regulatory Filings	2025-05-20	English
Change of Director's Interest Notice - MF 4 pages 9.1KB Regulatory Filings	2025-05-20	English
Change of Director's Interest Notice - JM 4 pages 9.1KB Regulatory Filings	2025-05-20	English
Phase I Clinical Trial Dosing Update No 3 4 pages 266.3KB Regulatory Filings	2025-05-20	English
Notice of Change of Interests of Substantial Holder - M Azzi 2 pages 221.8KB Regulatory Filings	2025-05-20	English
Application for quotation of securities - NYR 6 pages 18.4KB Regulatory Filings	2025-05-14	English
Cleansing Statement 2 pages 202.4KB Regulatory Filings	2025-05-14	English
Notification regarding unquoted securities - NYR 9 pages 29.2KB Regulatory Filings	2025-05-14	English
NYR-BI03 Extends Cardioprotection to Arrhythmia Control 5 pages 351.7KB Regulatory Filings	2025-05-07	English
Phase I Clinical Trial Dosing Update No 2 3 pages 244.4KB Regulatory Filings	2025-05-01	English
Results of Meeting 4 pages 267.7KB Regulatory Filings	2025-04-16	English
Quarterly Activities Report and Appendix 4C 9 pages 580.9KB Regulatory Filings	2025-04-14	English
Phase I Clinical Trial Dosing Update No 1 3 pages 322.7KB Regulatory Filings	2025-04-08	English
Notice of Initial Substantial Holder - M Azzi 2 pages 219.6KB Regulatory Filings	2025-04-08	English
Significant Neuroprotection in Traumatic Brain Injury Study 3 pages 356.0KB Regulatory Filings	2025-04-06	English
First Cohort Dosed in Nyradas Phase I Clinical Trial 4 pages 248.6KB Regulatory Filings	2025-03-30	English
Nyrada Commences Phase I Clinical Trial Recruitment 4 pages 249.0KB Regulatory Filings	2025-03-16	English
2025 EGM Letter to Shareholders, Notice of Meeting and Proxy 49 pages 1.9MB Regulatory Filings	2025-03-11	English
Appendix 4D and Half Year Report to 31 December 2024 20 pages 508.7KB Regulatory Filings	2025-02-17	English
Nyrada Half Year Results FY2025 5 pages 336.4KB Regulatory Filings	2025-02-17	English
Nyrada to Commence Phase Ia Clinical Trial 3 pages 246.4KB Regulatory Filings	2025-02-06	English
Change of Director's Interest Notice - JM 2 pages 6.2KB Regulatory Filings	2025-01-22	English
Quarterly Activities Report and Appendix 4C 9 pages 564.2KB Regulatory Filings	2025-01-22	English
Change of Director's Interest Notice - CC 2 pages 6.3KB Regulatory Filings	2025-01-21	English
Change of Director's Interest Notice - RW 3 pages 7.4KB Regulatory Filings	2025-01-21	English
Change of Director's Interest Notice - MF 2 pages 6.2KB Regulatory Filings	2025-01-21	English
Notification of cessation of securities - NYR 5 pages 18.4KB Regulatory Filings	2025-01-20	English
Change of Director's Interest Notice - ID 2 pages 6.0KB Regulatory Filings	2025-01-20	English